Thursday, 16 May 2019

Superdisintegrants Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin

Market Insights
Oral administration of medical drugs in the form of tablets and capsules is one of the most commonly prescribed methods for drug delivery due to several key factors ranging from being easy to swallow to better chemical stability in this form. Superdisintegrants have become a vital addition to tablets and capsules as they facilitate rapid disintegration of smaller doses than conventional disintegrants making them ideal for various medical applications in the pharmaceutical sector. Market Research Future's new publication on the global superdisintegrants market has observed the growth of the market at a healthy CAGR of 7.9% during the forecast period from 2018 to 2023. At the beginning of the forecast period in 2017, the market generated a revenue of USD 371.3 Mn. The projected rate of growth is anticipated to establish the market at a value of USD 576.2 Mn by the end of the review period in 2023
The global pharmaceutical industry has witnessed a significant spike in its growth over the past few years, and this growth is expected to continue in the coming years. Many patents on popular drugs have expired or are likely to expire soon, which has prompted the entry of new competitors and the production of generic drugs. Increasing production of generic drugs is expected to cause a rise in demand for superdisintegrants. Moreover, superdisintegrants are used highly in the production of drugs which are aimed at geriatric and pediatric patients as they offer good disintegration and efficacy at low dosages. The ever-expanding aged and infant population is likely to impact the global superdisintegrants market in a positive manner.
Emerging economies offer the global superdisintegrants market with considerable opportunities for growth over the forecast period. The prevalence of several chronic diseases combined with the rapidly expanding healthcare sector in the region will contribute to future growth of the market.
Market Segmentation
MRFR's analysis of the various segments in the market has been performed on the basis of type, formulation, therapeutic area, and region. Types of superdisintegrants have been segmented into synthetic superdisintegrants, natural disintegrants, and others. Among these, the synthetic superdisintegrants segment has been widely used, making it the most significant market segment. However, the natural superdisintegrants segment is growing at a truly rapid pace due to the growing demand for natural ingredients.
Formulations which include superdisintegrants have been segmented into tablets and capsules. Tablets govern a majority share of the total market, while the capsules segment is expected to grow at the highest CAGR during the review period.
Therapeutic areas where superdisintegrants are used have been segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, inflammatory diseases, hematological diseases, and cardiovascular diseases. Among these segments, the gastrointestinal diseases segment is at the forefront of market growth due to the demand for fast acting medicine for these types of diseases. Meanwhile, the oncology segment is growing rapidly and is expected to display the highest CAGR over the forecast period.
 Regional Analysis
Led by the U.S, the Americas have captured the largest share of the global superdisintegrants market. The presence of a developed healthcare sector as well as several important market players that have and continue to influence growth and contribute to the sizeable share that this regional market possesses. The region also has a high demand for drugs for many chronic diseases where superdisintegrants are required due to the prevalence of such diseases.
The Asia Pacific superdisintegrants market is likely to grow at the highest pace due to the concentration of rapidly emerging markets in the region. China, Japan, India, and several other country-level markets have a high demand for drugs for chronic diseases. The APAC regional market has several avenues for growth that are expected to open up in the coming years. The regions rapidly growing healthcare sector and the presence of a number of contract manufacturing organizations for pharmaceuticals is likely to have a positive impact on the market.
Key Players
Analysis of the competitive landscape of the global superdisintegrants market includes several important market players such as DFE Pharma, Roquette Freres, BASF SE, Ashland Global Holdings Inc., JRS Pharma, Merck KGaA, DowDuPont Inc., Avantor Performance Materials, LLC, Corel Pharma Chem, and Asahi Kasei Corporation.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , , , ,

Wednesday, 15 May 2019

Oral Mucositis Market Size, Share, Demand, Global Industry Overview and Forecast to 2023

Overview:
Prevalence of chronic disease such as cancer has multifarious effects on the human body. One such is oral mucositis where individuals suffer from painful lesions of the mucous membranes. This can be seen as a side-effect of the chemotherapy, and it is proportional to the growth of the chemotherapy dose. The disease can adversely affect an individual’s nutritional habits as it prevents the patient from chewing solid foods and even at times, from swallowing it. The global oral mucositis market can expect a growth of 7% during the forecast period (2017-2023), reveals Market Research Future (MRFR) in their thoroughly studied report. It further includes vital influencers and segments to provide a reliable prediction for the future market. Among chief drivers, recently patented drugs for oral mucositis are playing significant roles. Furthermore, several investments in research and development are also ensuring considerable market growth.
However, most of the medicines are costly, and some await clinical trial and license. This could deter the expected market growth during the forecast period.
However, most of the medicines are costly, and some await clinical trial and license. This could deter the expected market growth during the forecast period.
Industry Trend:
Innovation Pharmaceuticals has recently signed a contract with CoreEx to develop a drug product to formulate Brilacidin in granular form, and it will be available in sachets. This is to help patients suffering from head or neck cancer receiving chemoradiation.
Researchers at Iran’s Kerman University of Medical Sciences have recently declared that the intake of Omega 3 fatty acids could treat and prevent mucositis, bringing in relief for patients who have cancer.
Izun Pharmaceuticals Corporation has revealed that they have finished the Phase 2 clinical study of IZN-6N4 which has been manufactured using botanical resources. The study is showing positive results as patients are complaining less frequently about pain.
Segmentation:
The global oral mucositis market can be segmented by cause and end-users.
Based on cause, the oral mucositis market includes oral mucositis caused by chemotherapy, oral mucositis caused by radiotherapy, and hematopoietic stem cell transplantation.
Based on end-users, the oral mucositis market includes hospitals, dental clinics, oncology hospitals, and research institutes.
Regional Analysis:
The global oral mucositis market is divided by geography into the Americas, Europe, APAC, and the Middle East and Africa. The Americas dominate the global oral mucositis market due to the widespread prevalence of cancer and widespread use of chemo- and radiotherapy to treat it. On the other hand, the oral mucositis market in APAC is rising at a steady rate and is likely to emerge as a key segment in the coming years. In the Americas, particularly North America, branded drugs are the major medicine for oral mucositis due to the presence of a highly developed medical industry. The incidence rate of anal cancer is the highest in North America among these regional segments, making it the leader in the global oral mucositis market.
Europe, APAC, and MEA markets for oral mucositis are all expected to grow considerably over the forecast period, though the incidence of anal cancer in MEA is the lowest and is likely to remain low over the forecast period.
Market Landscape:
Strategies are proving essential in taking the oral mucositis market forward. Influential companies are getting involved in a merger, acquisition, new product launch, collaborations, and other tactics to stay abreast in this market. For instance, Catalent acquired Juniper Pharmaceuticals to expand its market hold and cement its foothold in Europe. AMAG Pharmaceuticals is planning on diversification by completing divestiture in cord blood registry.
Some of the players operating for the oral mucositis are Izun Pharmaceutical Ltd (US), Shoreline Pharmaceuticals Inc. (USA), Himalaya (India), AMAG Pharmaceuticals Inc. (USA), Kinnear Pharmaceuticals (US), Celleutix Corporation (USA), Soligenix Inc. (US), Oragenics (US), and others.  
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , , , ,

Tuesday, 14 May 2019

UTI Drugs Market | Global Market 2019 Study and Analysis Report

Market Highlights
UTI drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections. World Health Organization (WHO) estimates that approximately 50 % of women have UTI at some point in their lives resulting in more than $1 million hospitalizations per year. WHO estimates the cost of UTI infections to be annually greater than $1 billion. It has further been stated that chances of boys being diagnosed with UTI is 1% while chances of girls being diagnosed with UTI is 3 to 8%.
The Middle East and Africa UTI drugs market is growing due to factors such as catheter associated UTI, hospital borne infections (nosocomial infections), child birth, old age, obesity, growing health awareness especially about women health etc. On the other hand market constraints includes excellent efficacy of present antibiotics specially quinolones, growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc. However, the rise of drug resistance has created the need for novel acting antibiotic. The future of UTI treatment seems to be development of biologics with greater market development especially with respect to poorly growing African market. The loss of patents, weakening developed pipelines and poor expenditure on health in African region had further constrained the market growth.
The Middle East and Africa UTI drugs market has been segmented into drug class which includes quinolones, aminoglycosides, β-lactam, azoles and others. Among all these drug classes quinolones have the largest market value due to their broad variety and excellent efficacy. The share of aminoglycosides have been reduced by a small margin as this drug is resistance. Thus the current trend in UTI treatment is combined drug regimen. The market threat includes a form of substandard, counterfeit and spurious drugs have emerged. However it has to be noted that a huge unmet need exists for these drugs in the Middle East and African region.
Key Players:
Major participants of this market are: Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc., Dr. Reddy’s Laboratories Ltd. and others.
Middle East and Africa UTI Drugs market:
The Middle East and Africa UTI drugs market has been evaluated to be growing market and is expected that the market will grow moderately in the future. The Middle East and Africa UTI drugs market is expected to grow with the CAGR of 4.35% during the forecast period. The growth will primary be led by unmet medical needs and rising incomes of the population.
Regional Analysis:
Depending on geographic region, UTI drugs market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman; UAE is the largest market followed by Egypt. However the future market will be led by poorly developed parts of Africa due to large unmet needs. 
Market Segmentation:
Middle East and African UTI drugs market has been segmented on the basis of drug class which comprises of quinolones, aminoglycosides, β-lactam, azoles and others. On the basis of clinical Indications the market is segmented into urethritis, cystitis and pyelonephritis. On the basis of end users, market is segmented into hospitals and self-administered.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels: , , , , , ,

Friday, 10 May 2019

Live Cell Imaging Market Opportunities, Drivers, Manufacturers, Analysis and Forecasts Till 2023

Live cell imaging is a technique to study live cells with the help of images obtained with imaging systems such as microscopes and high content screening systems. Over the past few years, the adoption of high content screening techniques in drug discovery and cell biology has been continuously rising and so is growing the live cell imaging market.
You Can Get Free Sample Copy Of Live Cell Imaging Market Analysis Report @ https://www.marketresearchfuture.com/sample_request/6075


As a result, live cell imaging is pervasively gaining a considerable prominence, and its market is garnering colossal accruals. Moreover, the factors such as the increasing prevalence of chronic diseases and growing government funding in cell-based research are escalating the market on the global heights.
Acknowledging the exponential accruals, the market is witnessing currently, Market Research Future (MRFR), in its recently published study report, asserts that the global live cell imaging market will register approximately 9 % CAGR between 2018 -2023, garnering impressive growth by 2023.
Additional factors driving the market growth include the various applications of live cell imaging in the biotech and pharmaceutical industry and the rising prevalence of cancer worldwide. Furthermore, increasing approvals from regulatory bodies and spreading awareness foster the market growth. 
The increasing number of research activities in the pharmaceutical manufacturing and bioscience defines the augmented demand for live cell imaging and its increasing market size. Indeed, improving economic conditions, worldwide, are propelling the market growth, enabling access to the quality, and improved health care.
On the flip side, factors such as the lack of availability of skilled professional and the prohibitive costs associated with the high-content screening systems are some of the primary factors that are impeding the market growth. Nevertheless, the support rendered by developed countries in terms of funding and well-established market players is projected to support the market growth.

Global Live Cell Imaging Market- Segments
MRFR has segmented its analysis into five key dynamics for enhanced understanding.

By Products             : Equipment, Consumables, and Software
By Technology        : Fluorescence Resonance Energy Transfer, Fluorescence Recovery After Photobleaching, High-Content Analysis, Ratiometric Imaging, Fluorescence in Situ Hybridization, Total Internal Reflection Fluorescence Microscopy, and Multiphoton Excitation Microscopy among other Technologies.
By Application       : Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery among others.
By End-user             : Pharmaceutical Companies, Biotechnology Companies, Hospitals, and Diagnostic Laboratories among others.
By Regions              :  Europe, North America, APAC and Rest-of-the-World.

Global Live Cell Imaging Market- Regional Analysis
The North American region dominates the global Live Cell Imaging Market with substantial investments made into R&D activities in the biotech and pharmaceutical sectors.  Furthermore, factors such as the existing well-established healthcare system, the increasing prevalence of cancer cases, and technological advancements drive the market growth in the region.
Also, high capitalization in imaging systems as well as intensive research and development to improve the imaging quality and data functionality foster the market growth. Strong economic conditions in the region fuel the market growth, allowing funding required for research and development.  Moreover, the presence of giant players is impacting the market growth in the region, positively.
The European region heading with the increased focus on research and development, especially in the biotechnology sector, accounts for another lucrative market for live cell imaging. Factors such as the government funding support for R&D expenditure and rising prevalence chronic diseases are expected to drive the European live cell imaging market. Also, the presence of some of the notable players such as Leica Microsystems, Carl Zeiss AG, and GE Healthcare facilitates the market growth in the region.
The Asia Pacific live cell imaging market is rapidly emerging as a promising market.  The increasing number of research labs define the market landscape in the region. Also, rapidly improving economic conditions in the region alongside the growing cancer research activities and developing healthcare technology provide impetus to market growth in the region.
 Japan among other APAC countries accounts for the largest market for live cell imaging due to the increase in the prevalence of cancer and demand for live cell imaging techniques.  Whereas, in China, factors such as rising geriatric population with chronic diseases and the availability of low-cost diagnostic and treatment options drive the market growth.

Global Live Cell Imaging Market- Competitive Analysis
The competitive market of live cell imaging appears fragmented owing to the many large and small players along with the new entrants churning the competition. Due to the high growth potential and demand in the market; players also plan to increase production of the products used in the cell culture.
Key Players:
Some of the fervent players leading the global live cell imaging market include Leica Microsystems (Germany), Carl Zeiss AG (Germany), Olympus Corporation (Japan), Nikon Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Molecular Devices, LCC (U.S.), GE Healthcare (U.K.), PerkinElmer, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), BioTek Instruments (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Industry/Innovations/Related News:
December 06, 2018 – CELLINK company (Sweden), a leading global player in the market of universal Bioinks that are mixed with living cells to print functional human tissues announced signing partnership deal with Prellis Biologics Inc. (US), a leading global provider of holographic printing system able to match and accurately replicate human organ and tissue structures for R&D and organ transplantation. The partnership fosters commercialization of high-resolution holographic bioprinting technology for micro-printing.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,
Location: SD-34, Milesville, SD 57553, USA

Tuesday, 7 May 2019

Clinical Data Analytics Market Size Is Poised To Reach USD 11,853.6 million

Market Scenario
The global clinical data analytics market is considered to garner USD 11,853.6 million with 30.90% CAGR during the forecast period (2016-2022) owing to the surging technological advancements in mHealth, asserts Market Research Future (MRFR). A brand-new approach, clinical data analytics is shifting towards new payment modes and the absolute amount of clinical data stored in Electronic Health Records
(EHR). Healthcare professionals are opting for analytic solutions for population management solutions.

Drivers and Constraints Impacting the Market
The healthcare sector has experienced a paradigm shift in the last few years owing to the high adoption of electronic health records (EHRs), which has resulted in the integration of the digital world with the physical. This has further resulted to a seismic shift in the quality and volume of clinical data. The integration of analytics has benefitted the healthcare industry in several ways. The healthcare sector has been facilitated with the benefit to record datasets and valuable information ranging from patient preferences, therapies to medical history and procedures which has been proven to be effective in treating injuries and diseases. Additionally, provision of evidence-based treatments offered to the patients, feasibility of preventive care over reactive care, and facility of personalized care are some of the factors considered to push the market growth during the appraisal period. Moreover, clinical analytics minimizes the avoidable readmissions and upgrades patient outcomes, and also enables the hospitals to shift towards value-based quality of care. Such factors are estimated to fuel the market growth in the coming years.
On the flip side, some of the developing countries are still struggling to offer better internet facilities to their citizens, who are unable to take the advantage of the social and economic benefits offered by the internet. People belonging to the lower economic classes in the poor and developing countries are still devoid of clinical data analytics. Moreover, privacy and security issues in managing and handling of clinical data are among the serious concerns likely to slow down the market growth.
Segmental Analysis
The market for clinical data analytics has been segmented on the basis of deployment model, application and end users. By deployment model, the segmentation comprises of on-premise and cloud based. On the basis of application, the market is segmented into population health management, quality care, precision health, clinical detection support, reporting, and compliance. By end user, the market is segmented into healthcare providers, pharmaceutical companies, academics & research institutes and others. The regions encompassed in the study are North America, Europe, Africa, Asia Pacific, and the Middle East.

Regional Insights
Geographically, the clinical data analytics market has been studied under regions namely, Europe, North America, Asia Pacific, and the Middle East & Africa.
Among all the regions, the Asia Pacific region is estimated to experience the fastest growth rate at a CAGR of 31.42%. The growth is mainly credited to the adoption of big data analytics by the healthcare providers. China is considered as the hotspot for clinical data analytics in this region owing to the accelerating patient population, augmenting opportunity in the pharmaceutical industry, and rising drug development cost. Contract research organizations, multi-national pharmaceutical companies, service providers, and academic institutions have taken the advantage of the regulatory changes made recently in China in order to establish their presence in the industry. This has highly influenced the market growth in this region.
The North American region occupies the largest market share and is anticipated to garner USD 6,293.2 million by the end of 2022. The growth is credited to the emanation of big data in the healthcare sector, growing clinical data management for improved healthcare outcomes, establishment of healthcare policies the by government, and surging technological developments along with R&D for precision medicines.

Industry Updates
March 2018: MedConnect and Clinigence has recently partnered in order to provide improved value-based programs for clinical data analytics. Such products help in risk mitigation since they keep maturing.
Competitive Dashboard
The prominent players operating the global clinical data analytics market are International Business Machines Corporation (U.S.), Cerner (U.S.), McKesson (U.S.), Xerox (U.S.), Athenahealth Inc. (U.S.), and others.

Industry Updates:
Aug 2018 Nuance Communications Inc. recently revealed the general availability of a cloud-based version of its mPower Clinical Analytics platform for radiology. The mPower Clinical Analytics will help radiologists improve performance improvement strategies via industry benchmarks and best practices.
Posted by at No comments:
Labels: , , , , ,

Thursday, 2 May 2019

Increasing Technological Advancement In Hemostats Market – Global Industry Forecast to 2023

Market Highlights
Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion. Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly with technological advancements and a growing number of surgeries. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the hemostats market.
The hemostats market is expected to grow at a CAGR of 6.4%.
However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market.
Segmentation
The global hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.
On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.  On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps. On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.
Regional Analysis
The Americas is projected to lead the hemostats market in the forecast period. Rising rate in a number of diseases due to various factors such as a change in lifestyle, rising geriatric population and others contribute majorly to the growth of the market. Increasing healthcare awareness, advancement in technology, medical tourism, and an increase in disposable income are some other factors that boost the growth of the market.  According to the United States Center for Disease Control and Prevention, around 45% of the American population is suffering from at least one chronic condition demanding critical care.
The European market is expected to hold the second largest market share. Introduction of technologically advanced hemostat products such as FLOSEAL, HEMOPATCH, and TISEEL is projected to boost the demand for these products in the European market. The European hemostats market is anticipated to be driven due to the increase in the elderly aged population, which is expected to ultimately lead to a higher number of surgeries. The European market is projected to grow because of the increase in elderly population, growing prevalence of diabetes, and heart rhythm problems in the region.
Asia-Pacific was projected to be the fastest growing region for the global hemostats market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Key Players
Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation (US).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , , , , , , ,

Sunday, 28 April 2019

Global Healthcare Biometrics Market Is Expected to grow USD 5.6 Billion By 2023

Market Analysis
The global healthcare biometrics market is fast growing and promising and is projected to touch USD 5.6 billion at a staggering 22.3% CAGR over the forecast period (2016-2022). Biometrics has changed the look and perception of the healthcare domain. Healthcare biometrics are various biometric applications that are used in clinics and hospitals for monitoring patient’s health. Healthcare organizations mainly clinical research organizations, diagnostic laboratories, health insurers, manufacturing companies and hospitals are its potential users. The healthcare officials these days are leveraging unique ways to use the biometrics techniques namely iris scanners, palm vein readers, finger print scanners, facial recognition solutions amid others. Decrease in inventory theft, control on medical frauds, safe data recording and integrity of patient identity are the distinct benefits that biometrics offer. Implementing such emerging technologies are making it simpler for payers, practices, hospitals and other forms of healthcare organizations in recognizing individual patients and matching the medical data of the patient that holds considerable promise.
There are many factors that is fueling the growth of the healthcare biometrics market. The different market trends and factors in this market according to an analysis performed by Market Research Future (MRFR) include increasing healthcare IT application, burgeoning need for cyber security, increasing biometric development that caters to healthcare facilities, safe treatment, increasing incidences of medical identity theft and healthcare fraud, growing population, initiatives taken by the government to support biometrics implementation in healthcare facilities and improving economic conditions. On the contrary, factors such as soaring expenditure of biometric devices coupled with issues associated to the use of this technology may limit healthcare biometrics market growth.
Global Healthcare Biometrics Market   - Segments
MRFR has segmented its analysis into four key dynamics for enhanced understanding.
 By Technologies    : Face Recognition, Fingerprint Recognition, Vein Recognition, Behavioral Recognition, Iris Recognition, and Palm Geometry Recognition among others.
By Applications     : Patient Identification, Patient Monitoring, Medical Record Management, Data Security, and others.
By End-users           : Hospitals, Research Laboratories, and Healthcare Institutes among others.
By Regions              :  Europe, North America, APAC and the Rest-of-the-World.
Regional Analysis
Based on region, the healthcare biometrics market covers growth opportunities and latest trends across Europe, North America, Asia Pacific and Rest of the World. Of these, North America will garner a huge prominence in the market owing to the growing demand for the regulatory requests and the well-established healthcare domain. Besides, factors such as the proliferating healthcare insurance industry, extensive use of biometrics in hospitals and rising digital advancements in the medical technology, significance of electronic medical records and need for user-friendly software are driving the growth of the market here. US is the largest contributor as it is backed with data security, patient monitoring, medical record management, patient identification and developments in authentic solutions. The healthcare biometrics market in Europe is highly lucrative and grabs the second position owing to the increasing need for healthcare biometrics across the region. The other factors that are contributing to the growth of the market here include the resurging economy and increased funding. In the APAC region, the healthcare biometrics market is emerging rapidly with high growth opportunities owing to the burgeoning healthcare sector, rapidly developing technologies and biometric models, improving economic conditions and market penetration.
Competitive Analysis
The healthcare biometrics market is fragmented and highly competitive due to the existence of various small and big market players together with new participants churning the competition. The leading players are implementing strategic trends to expand the business in the emerging markets. They are laying emphasis on optimized situational cognizance for customers to ensure their mission success. The matured players with the help of different strategies namely innovations, mergers and acquisitions and collaboration are constantly seeking market expansion. These players are investing increasingly in research and development activities and developing cost-effective product range. They possess cutting edge facilities for developing software and strong distribution and sales network that have helped them in gaining a leadership position in the healthcare biometrics market. The marketers that are operating in clinical practice management are laying emphasis on generating inbound leads more than ever.
Key Players:
Some of the eminent leaders of the market include 3M Cogent Inc., Fujitsu Limited, BioEnable Technologies, Morpho (A Subsidiary of Safran SA), NEC Corporation, Bio-Key International, Inc., Crossmatch Technologies Inc., Suprema, Inc., Integrated Biometrics, and Imprivata Inc.
Intended Audience:
  • Healthcare Biometrics equipment manufacturers
  • Healthcare Biometrics equipment suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Academic Institutes and Universities
Industry/ Innovation /Related News:
October 10, 2018 – Ipsidy Inc. (US), a leading global provider of trusted transactions with identity at the core & enhances security with biometric identity & multi-factor authentication mobile solutions announced a partnership with Safetrade Africa to extend its distribution reach in the African market.  Safetrade will act as a reseller in southern African countries and the Indian Ocean islands of Madagascar, Mauritius, and Seychelles.
August 13, 2018 – Ipsidy Inc. (US) announced the launch of Access™ Mobile Biometric Perimeter Protection Access is a mobile, biometric identity access management solution that helps in protecting any perimeter & create a safe environment, monitoring the identities of enrolled people moving in and out around any defined area.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)